| Heading: |
Pancreatic Enzyme Replacement Therapy: Shortages |
| Question ID: |
1784868 |
| UIN: |
38463 |
| House: |
Commons |
| Date tabled: |
2025-03-14 |
| Asking Member ID: |
5111 |
| Asking Member display name: |
Martin Wrigley
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Martin Wrigley
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will convene a stakeholder roundtable to help tackle the shortage of Pancreatic enzyme replacement therapy medication with (a) manufacturers, (b) patient advocacy groups and (c) other relevan |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-21 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
There are no current plans to convene such a roundtable. The Department is in regular discussion with the suppliers of pancreatic enzyme replacement therapy (PERT) on the latest stock availability and the actions that are being taken to mitigate the suppl... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |